Armata Pharmaceuticals (ARMP)
(Delayed Data from AMEX)
$2.36 USD
-0.01 (-0.42%)
Updated Oct 14, 2024 03:06 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Cash flow Statements
Fiscal Year End for Armata Pharmaceuticals, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -69.05 | -36.92 | -23.16 | -22.18 | -19.48 |
Depreciation/Amortization & Depletion | 0.97 | 0.89 | 1.17 | 1.11 | 1.35 |
Net Change from Assets/Liabilities | -9.65 | 0.44 | -3.22 | -0.87 | -2.19 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 30.30 | 3.11 | 1.63 | 3.67 | 4.74 |
Net Cash From Operating Activities | -47.42 | -32.48 | -23.58 | -18.27 | -15.58 |
Property & Equipment | -8.13 | -2.21 | -1.30 | -0.82 | -0.13 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 3.01 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -8.13 | -2.21 | -1.30 | -0.82 | 2.88 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.01 | 44.52 | 26.93 | 23.06 | 9.98 |
Issuance (Repayment) of Debt | 54.03 | 0.00 | 0.00 | 0.72 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -0.04 | -0.50 | -1.41 | -0.57 | -1.00 |
Net Cash from Financing Activities | 53.99 | 44.02 | 25.52 | 23.21 | 8.98 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -1.57 | 9.32 | 0.64 | 4.12 | -3.73 |
Cash at Beginning of Period | 20.81 | 11.49 | 10.85 | 6.73 | 10.46 |
Cash at End of Period | 19.24 | 20.81 | 11.49 | 10.85 | 6.73 |
Diluted Net EPS | -1.91 | -1.08 | -0.96 | -1.35 | -2.55 |
Fiscal Year End for Armata Pharmaceuticals, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -16.04 | -25.02 | -69.05 | -49.20 |
Depreciation/Amortization & Depletion | NA | 0.63 | 0.32 | 0.97 | 0.68 |
Net Change from Assets/Liabilities | NA | -2.35 | -1.69 | -9.65 | -10.20 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | -3.01 | 15.81 | 30.30 | 19.41 |
Net Cash From Operating Activities | NA | -20.76 | -10.58 | -47.42 | -39.32 |
Property & Equipment | NA | -1.62 | -0.25 | -8.13 | -5.74 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | NA | -1.62 | -0.25 | -8.13 | -5.74 |
Uses of Funds
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 0.13 | 0.04 | 0.01 | 0.01 |
Issuance (Repayment) of Debt | NA | 34.89 | 34.89 | 54.03 | 54.03 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | 0.00 | 0.00 | -0.04 | 0.00 |
Net Cash from Financing Activities | NA | 35.02 | 34.93 | 53.99 | 54.03 |
Effect of Exchange Rate Changes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | NA | 12.64 | 24.10 | -1.57 | 8.97 |
Cash at Beginning of Period | NA | 19.24 | 19.24 | 20.81 | 20.81 |
Cash at End of Period | NA | 31.89 | 43.34 | 19.24 | 29.78 |
Diluted Net EPS | NA | 0.25 | -0.69 | -0.48 | -0.86 |